1-Tert-butyl-3-ethoxy-3-methylazetidine | 1353650-30-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氮杂环丁烷
• 英文名称: 1-Tert-butyl-3-ethoxy-3-methylazetidine
• 英文别名: 1-tert-butyl-3-ethoxy-3-methylazetidine
• CAS: 1353650-30-2
• 化学式: C₁₀H₂₁NO
• 分子量: 171.283
• InChiKey: OJUBCFNOFHMLKH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2,3-dibromo-N-(tert-butyl)-2-methylpropan-1-amine 反应 12.0h， 生成 1-Tert-butyl-3-ethoxy-3-methylazetidine
  参考文献：
  名称：

  Synthesis of 3-functionalized 3-methylazetidines

  摘要：

  1-t-Butyl- and 1-(4-methylbenzyl)-3-bromo-3-methylazetidines were prepared from the corresponding N-(2,3-dibromo-2-methylpropylidene)alkylamines and their propensity to undergo nucleophilic substitution at the 3-position by different nucleophiles was assessed, providing a convenient access to novel 3-alkoxy-, 3-aryloxy-, 3-hydroxy-, 3-cyano-, 3-carboxy-, 3-(aminomethyl)- and 3-(hydroxymethyl)azetidines. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2011.10.097

文献信息

• Biheteroaryl compounds and uses thereof
  申请人：Genentech, Inc.

  公开号：US11129832B2

  公开（公告）日：2021-09-28

  The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula I-I all have the meaning as defined herein.

  本发明提供了用于治疗疾病（如神经退行性疾病）的式-I-I化合物及其实施方案和盐。式-I-I中的R1、R2、R3、X1、X2、A和Cy变量均具有本文所定义的含义。
• BIHETEROARYL COMPOUNDS AND USES THEREOF
  申请人：Genentech, Inc.

  公开号：US20200188397A1

  公开（公告）日：2020-06-18

  The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R 1 , R 2 , R 3 , X 1 , X 2 , A and Cy variable in Formula I-I all have the meaning as defined herein.